Natera Dividends and Buybacks
Dividend criteria checks 0/6
Natera does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-0.1%
Buyback Yield
| Total Shareholder Yield | -0.1% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Subdued Growth No Barrier To Natera, Inc. (NASDAQ:NTRA) With Shares Advancing 25%
Nov 19
Natera, Inc. (NASDAQ:NTRA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$158
Nov 15Natera And GeneDx: Outperforming Market Powered By Precision Medicines Tailwinds
Oct 31Natera, Inc.'s (NASDAQ:NTRA) Intrinsic Value Is Potentially 20% Below Its Share Price
Sep 18Does Natera (NASDAQ:NTRA) Have A Healthy Balance Sheet?
Jul 05Natera: Overdue For A Breather
Jun 03Natera, Inc. (NASDAQ:NTRA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$119
May 12Is There An Opportunity With Natera, Inc.'s (NASDAQ:NTRA) 41% Undervaluation?
Mar 30Natera: Capitalizing On The Positive Momentum Of Personalized Medicine
Mar 22Is Natera (NASDAQ:NTRA) A Risky Investment?
Mar 03Estimating The Fair Value Of Natera, Inc. (NASDAQ:NTRA)
Dec 11Is Natera (NASDAQ:NTRA) A Risky Investment?
Nov 10Natera, Inc. (NASDAQ:NTRA) Shares Could Be 46% Below Their Intrinsic Value Estimate
Aug 07Health Check: How Prudently Does Natera (NASDAQ:NTRA) Use Debt?
May 16Natera, Inc.'s (NASDAQ:NTRA) Low P/S No Reason For Excitement
Apr 18Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if NTRA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NTRA's dividend payments have been increasing.
Dividend Yield vs Market
| Natera Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (NTRA) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.2% |
| Industry Average (Biotechs) | 2.3% |
| Analyst forecast (NTRA) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate NTRA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NTRA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate NTRA's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as NTRA has not reported any payouts.